Clinical Trials Browser

Phase 1 × Recruiting × Metastatic Castration Resistant Prostate Cancer × Clear all

NCT06830850 2026-01-15

A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Phase 1 Recruiting

Metastatic Castration Resistant Prostate Cancer